Yahoo
TSXV - Delayed Quote CAD

MedMira Inc. (MIR.V)

0.0500 0.0000 (0.00%)
At close: October 27 at 9:30:00 AM EDT
Chart Range Bar
Loading chart for MIR.V
  • Previous Close 0.0500
  • Open 0.0500
  • Bid 0.0500 x --
  • Ask 0.0550 x --
  • Day's Range 0.0500 - 0.0500
  • 52 Week Range 0.0500 - 0.0800
  • Volume 10,000
  • Avg. Volume 57,311
  • Market Cap (intraday) 35.087M
  • Beta (5Y Monthly) 0.78
  • PE Ratio (TTM) --
  • EPS (TTM) -0.0000
  • Earnings Date (est.) --
  • Forward Dividend & Yield -- (0.00%)
  • Ex-Dividend Date --
  • 1y Target Est --

MedMira Inc., a biotechnology company, researches, develops, manufactures, and sells rapid diagnostics and technology platforms in North America, Europe, and internationally. The company offers Reveal HIV, a test that detects antibodies to HIV-1 and HIV-2 in whole blood, serum, or plasma; Reveal TP, a rapid syphilis antibody test that detects treponema pallidum antibodies in serum, plasma, or whole blood; Multiplo, a line of multiplex tests for HIV-1/2, Hepatitis B and C, and syphilis; and Miriad triple product for preliminary screening of HIV and hepatitis. It also provides the Miriad RVF toolkit, which facilitates the development and commercialization of rapid diagnostics; and Reveal G4 HIV tests. The company was founded in 1993 and is headquartered in Halifax, Canada. MedMira Inc. is a subsidiary of MedMira Holding AG.

medmira.com

--

Full Time Employees

July 31

Fiscal Year Ends

Healthcare

Sector

Biotechnology

Industry

Recent News

View More

Performance Overview

Trailing total returns as of 10/30/2026, which may include dividends or other distributions. Benchmark is S&P/TSX Composite index (^GSPTSE) .

YTD Return

MIR.V
28.57%
S&P/TSX Composite index (^GSPTSE)
11.78%

1-Year Return

MIR.V
44.44%
S&P/TSX Composite index (^GSPTSE)
18.03%

3-Year Return

MIR.V
44.44%
S&P/TSX Composite index (^GSPTSE)
88.90%

5-Year Return

MIR.V
61.54%
S&P/TSX Composite index (^GSPTSE)
69.32%

Statistics

View More

Valuation Measures

Annual
  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (current)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.00%

  • Return on Assets (ttm)

    -34.28%

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    370.57k

  • Net Income Avi to Common (ttm)

    -2.99M

  • Diluted EPS (ttm)

    -0.0000

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    --

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    -119.08k

Company Insights

Research Reports

View More

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: